Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• 主要な著者: Hamdy SM (著者), Abdel-Naseer M (著者), Shehata HS (著者), Hassan A (著者), Elmazny A (著者), Shalaby NM (著者), Abokrysha NT (著者), Kishk NA (著者), Nada MAF (著者), Ahmed SM (著者), Hegazy MI (著者), Mekkawy D (著者), Mourad HS (著者), Abdelalim A (著者), Berger T (著者)
• フォーマット: 図書
• 出版事項: Dove Medical Press, 2020-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...